Exploring mechanisms of psychedelic action using neuroimaging

被引:7
|
作者
David Erritzoe
Christopher Timmermann
Kate Godfrey
Pedro Castro-Rodrigues
Joseph Peill
Robin L. Carhart-Harris
David J. Nutt
Matthew B. Wall
机构
[1] Imperial College London,Division of Psychiatry, Faculty of Medicine
[2] Imperial College London,Centre for Psychedelic Research and Neuropsychopharmacology
[3] Centro Hospitalar Psiquiátrico de Lisboa,undefined
[4] University of California,undefined
[5] Invicro,undefined
来源
Nature Mental Health | 2024年 / 2卷 / 2期
关键词
D O I
10.1038/s44220-023-00172-3
中图分类号
学科分类号
摘要
Modern psychedelic research and clinical development is at a crucial inflection point, with great potential for the treatment of many mental illnesses demonstrated but significant questions that remain unresolved. Neuroimaging has been pivotal in the modern era of psychedelic research, providing crucial insights into the acute effects of these drugs that revealed translational, clinical potential. Here we review this evidence from functional magnetic resonance imaging, positron emission tomography and magnetoencephalography/electroencephalography studies and describe how these findings inform computational models of both the acute action of psychedelics and their longer-term therapeutic effects. This approach, based on multi-modal neuroimaging, provides a solid evidence base for these therapies as they move forwards, as well as a fuller understanding of the powerful effects of psychedelics on the phenomenology of human consciousness.
引用
收藏
页码:141 / 153
页数:12
相关论文
共 50 条
  • [31] Type 2 Diabetes and Memory: Using Neuroimaging to Understand the Mechanisms
    Jones, Nicola
    Riby, Leigh M.
    Mitchell, Rachel L. C.
    Smith, Michael A.
    CURRENT DIABETES REVIEWS, 2014, 10 (02) : 118 - 123
  • [32] Using neuroimaging to understand the cortical mechanisms of auditory selective attention
    Lee, Adrian K. C.
    Larson, Eric
    Maddox, Ross K.
    Shinn-Cunningham, Barbara G.
    HEARING RESEARCH, 2014, 307 : 111 - 120
  • [33] Exploring the mechanisms of action of FB642 at the cellular level
    Lisa A. Hammond
    Karen Davidson
    Richard Lawrence
    James B. Camden
    Daniel D. Von Hoff
    Steve Weitman
    Elzbieta Izbicka
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 301 - 313
  • [34] Tackling antimicrobial resistance by exploring new mechanisms of antibiotic action
    de Opitz, Cruz L. Matos
    Sass, Peter
    FUTURE MICROBIOLOGY, 2020, 15 (09) : 703 - 708
  • [35] Exploring the mechanisms of action of FB642 at the cellular level
    Hammond, LA
    Davidson, K
    Lawrence, R
    Camden, JB
    Von Hoff, DD
    Weitman, S
    Izbicka, E
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (05) : 301 - 313
  • [36] Exploring the anticancer potential and mechanisms of action of natural coumarins and isocoumarins
    Aqib, Mohd
    Khatoon, Shahnaaz
    Ali, Mujahid
    Sajid, Shabana
    Assiri, Mohammed Ali
    Ahamad, Shakir
    Saquib, Mohammad
    Hussain, Mohd Kamil
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 282
  • [37] Mechanisms of integration in psychedelic-assisted therapy
    Coverdale, Nicole S.
    Cook, Douglas J.
    JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH, 2023, 9 (05): : 38 - 55
  • [38] Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
    Stoliker, Devon
    Egan, Gary F.
    Friston, Karl J.
    Razi, Adeel
    PHARMACOLOGICAL REVIEWS, 2022, 74 (04) : 876 - 917
  • [39] Classic Psychedelic Drugs: Update on Biological Mechanisms
    Vollenweider, Franz X.
    Smallridge, John W.
    PHARMACOPSYCHIATRY, 2022, 55 (03) : 121 - 138
  • [40] Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action
    dos Santos, Rafael Guimaraes
    Hallak, Jaime E. C.
    Baker, Glen
    Dursun, Serdar
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (04) : 453 - 458